Cargando…

Non-pharmacological management options for MAFLD: a practical guide

Lifestyle changes should be the main basis for any treatment for metabolic dysfunction–associated fatty liver disease (MAFLD), aiming to increase energy expenditure, reduce energy intake and improve the quality of nutrients consumed. As it is a multifactorial disease, approaches such as physical exe...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefano, José Tadeu, Duarte, Sebastião Mauro Bezerra, Ribeiro Leite Altikes, Renato Gama, Oliveira, Claudia P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031614/
https://www.ncbi.nlm.nih.gov/pubmed/36968655
http://dx.doi.org/10.1177/20420188231160394
_version_ 1784910644535885824
author Stefano, José Tadeu
Duarte, Sebastião Mauro Bezerra
Ribeiro Leite Altikes, Renato Gama
Oliveira, Claudia P.
author_facet Stefano, José Tadeu
Duarte, Sebastião Mauro Bezerra
Ribeiro Leite Altikes, Renato Gama
Oliveira, Claudia P.
author_sort Stefano, José Tadeu
collection PubMed
description Lifestyle changes should be the main basis for any treatment for metabolic dysfunction–associated fatty liver disease (MAFLD), aiming to increase energy expenditure, reduce energy intake and improve the quality of nutrients consumed. As it is a multifactorial disease, approaches such as physical exercise, a better dietary pattern, and possible pharmacological intervention are shown to be more efficient when used simultaneously to the detriment of their applications. The main treatment for MAFLD is a lifestyle change consisting of diet, activity, exercise, and weight loss. The variables for training prescription such as type of physical exercise (aerobic or strength training), the weekly frequency, and the intensity most indicated for the treatment of MAFLD remain uncertain, that is, the recommendations must be adapted to the clinical conditions comorbidities, and preferences of each subject in a way individual. This review addresses recent management options for MAFLD including diet, nutrients, gut microbiota, and physical exercise.
format Online
Article
Text
id pubmed-10031614
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-100316142023-03-23 Non-pharmacological management options for MAFLD: a practical guide Stefano, José Tadeu Duarte, Sebastião Mauro Bezerra Ribeiro Leite Altikes, Renato Gama Oliveira, Claudia P. Ther Adv Endocrinol Metab New Insights in MAFLD Lifestyle changes should be the main basis for any treatment for metabolic dysfunction–associated fatty liver disease (MAFLD), aiming to increase energy expenditure, reduce energy intake and improve the quality of nutrients consumed. As it is a multifactorial disease, approaches such as physical exercise, a better dietary pattern, and possible pharmacological intervention are shown to be more efficient when used simultaneously to the detriment of their applications. The main treatment for MAFLD is a lifestyle change consisting of diet, activity, exercise, and weight loss. The variables for training prescription such as type of physical exercise (aerobic or strength training), the weekly frequency, and the intensity most indicated for the treatment of MAFLD remain uncertain, that is, the recommendations must be adapted to the clinical conditions comorbidities, and preferences of each subject in a way individual. This review addresses recent management options for MAFLD including diet, nutrients, gut microbiota, and physical exercise. SAGE Publications 2023-03-21 /pmc/articles/PMC10031614/ /pubmed/36968655 http://dx.doi.org/10.1177/20420188231160394 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle New Insights in MAFLD
Stefano, José Tadeu
Duarte, Sebastião Mauro Bezerra
Ribeiro Leite Altikes, Renato Gama
Oliveira, Claudia P.
Non-pharmacological management options for MAFLD: a practical guide
title Non-pharmacological management options for MAFLD: a practical guide
title_full Non-pharmacological management options for MAFLD: a practical guide
title_fullStr Non-pharmacological management options for MAFLD: a practical guide
title_full_unstemmed Non-pharmacological management options for MAFLD: a practical guide
title_short Non-pharmacological management options for MAFLD: a practical guide
title_sort non-pharmacological management options for mafld: a practical guide
topic New Insights in MAFLD
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031614/
https://www.ncbi.nlm.nih.gov/pubmed/36968655
http://dx.doi.org/10.1177/20420188231160394
work_keys_str_mv AT stefanojosetadeu nonpharmacologicalmanagementoptionsformafldapracticalguide
AT duartesebastiaomaurobezerra nonpharmacologicalmanagementoptionsformafldapracticalguide
AT ribeiroleitealtikesrenatogama nonpharmacologicalmanagementoptionsformafldapracticalguide
AT oliveiraclaudiap nonpharmacologicalmanagementoptionsformafldapracticalguide